Translocation (3;8)(q27;q24) in two cases of triple hit lymphoma

Cancer Genetics and Cytogenetics

Volumn 203, Issue 2, 2010, Pages 328-332

  Motlló, Cristina ^a   Grau, Javier ^a   Juncà, Jordi ^a   Ruiz, Neus ^a   Mate, José Luis ^a   Orna, Elisa ^a   Navarro, José Tomás ^a   Vives, Susana ^a   Sancho, Juan Manuel ^a   Esteban, Daniel ^a   Granada, Isabel ^a   Feliu, Evarist ^a   Ribera, Josep Maria ^a   Millá, Fuensanta ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; CISPLATIN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; METHYLPREDNISOLONE; MYC PROTEIN; PREDNISONE; PROTEIN BCL 2; PROTEIN BCL 6; RITUXIMAB; VINCRISTINE;

ABDOMINAL DISEASE; ADULT; AGED; ARTICLE; B LYMPHOCYTE; BACKACHE; BURKITT LYMPHOMA; CASE REPORT; CHROMOSOME TRANSLOCATION 3; CHROMOSOME TRANSLOCATION 8; DIABETES MELLITUS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KARYOTYPE; LARGE CELL LYMPHOMA; LIVER BIOPSY; LYMPH NODE BIOPSY; LYMPHADENOPATHY; LYMPHOCYTIC INFILTRATION; LYMPHOMA; MALE; MEDIASTINUM DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PALLIATIVE THERAPY; PELVIS TUMOR; PLEURA EFFUSION; PRIORITY JOURNAL; TREATMENT RESPONSE; TRIPLE HIT LYMPHOMA;

ADULT; AGED; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 8; CYTOGENETICS; DNA-BINDING PROTEINS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LYMPHOMA, B-CELL; MALE; NUCLEIC ACID HYBRIDIZATION; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC; TRANSLOCATION, GENETIC;

EID: 78650013516     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2010.08.018     Document Type: Article

References (14)

1. Swerdlow H.S., Campo E., Harris N.L., Jaffe E.S., Pileri S.A., Stein H., et al. WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues 2008, International Agency for Research on Cancer, Lyon, France. 4th edition.
2. Bertrand P., Bastard C., Maingonnat C., Jardin F., Maisonneuve C., Courel M.-N., et al. Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas. Leukemia 2007, 21:515-523.
3. The International Non-Hodgkin's Lymphoma Prognostic Factors Project A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993, 329:987-994.
4. Oriol A., Ribera J.M., Bergua J., Giménez Mesa E., Grande C., Esteve J., et al. High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma: comparison of results in human immunodeficiency virus-infected and noninfected patients. Cancer 2008, 113:117-125.
5. Boerma E.G., Siebert R., Kluinn P.M., Baudis M. Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of today's knowledge. Leukemia 2009, 23:225-234.
6. Wang H.Y., Bossler A.D., Schaffer A., Tomczak E., DiPatri D., Frank D.M., et al. A novel t(3;8)(q27;q24.1) simultaneously involving both the BCL6 and MYC genes in a diffuse large B-cell lymphoma. Cancer Genet and Cytogenet 2007, 172:45-53.
7. Sandlund J.T., Kastan M.B., Kennedy W., Behm F., Entrekin E., Pui C.H., et al. A subtle t(3;8) in plausible juxtaposition of MYC and BCL6 in a child with Burkitt lymphoma/leukaemia and ataxia telangiectasia. Cancer Genet Cytogenet 2006, 168:69-72.
8. Tomita N., Tokinaka M., Nakamura N., Takeuchi K., Koiky J., Motomura S., et al. Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations. Haematologica 2009, 94:935-943.
9. Savage K.J., Johnson N.A., Ben-Neriah S., Connors J.M., Sehn L.H., Farinha P., et al. MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy. Blood 2009, 114:3533-3537.
10. Xu Y., McKenna R.W., Molberg K.H., et al. Clinicopathologic analysis of CD10+ and CD10- diffuse large B-cell lymphoma: identification of a high-risk subset with coexpression of CD10 and bcl-2. Am J Clin Pathol 2001, 16:183-190.
11. Uherova P., Ross C.W., Schnitzer B., Singleton T.P., Finn W.G. The clinical significance of CD10 antigen expression in diffuse large B-cell Lymphoma. Am J Clin Pathol 2001, 115:582-588.
12. Hans C.P., Weisenburger D.D., Greiner T.C., Gascoyne R.D., Delabie J., Ott G., et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004, 103:275-282.
13. Zhao X.F., Hassan A., Perry A., Ning Y., Stass S.A., Dehner P. C-MYC rearrangements are frequent in aggressive mature B-cell lymphoma with atypical morphology. Int J Clin Exp Pathol 2008, 1:65-74.
14. Snuderl M., Kolman O.K., Chen Y.B., Hsu J.J., Ackerman A.M., Cin P.D., et al. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma. Am J Surg Pathol 2010, 34:327-340.